Colchicine, an anti-inflammatory drug that has been used for centuries for gout, has been shown to prevent cardiovascular disease in patients who have ever had a heart attack or who suffer from narrowed coronary arteries. A low dose of the drug reduces the chance of this by 30 percent, according to a study by the Radboud university medical center. The hospital reports this.
Cardiologist and professor Jan Hein Cornel: “We looked at the effect of Colchicine in more than 5,500 patients who had a heart attack or had narrowed coronary arteries in the past. Half of the patients received 0.5 mg of Colchicine every day, the rest a placebo. ”
Less heart attacks
The researchers saw that fewer heart attacks occurred in the group that received Colchicine. These people also required angioplasty surgery much less often. There was no difference in side effects between the groups, whose patients participated in the study for an average of 2.5 years.
Colchicine is a natural anti-inflammatory agent that has been used for centuries to treat conditions such as gout. It is extracted from autumn crocus, a crocus-like plant. Heart attacks are caused by arteriosclerosis, a long-term process that is exacerbated by chronic inflammation. The idea of using this medicine against cardiovascular disease came about when doctors saw that rheumatism patients who received the medicine had less cardiovascular disease. A low dose immediately after a heart attack prevents angioplasty treatment. This study is the first to show that the drug can also prevent subsequent cardiovascular disease in chronic heart patients.
By: Nationale Zorggids